Anhui Fengyuan Pharmaceutical Co Ltd
Anhui Fengyuan Pharmaceutical Co., Ltd. researches and develops, produces, and sells medicines in China. The company also exports its products. Anhui Fengyuan Pharmaceutical Co., Ltd. was incorporated in 1997 and is based in Hefei, China.
Anhui Fengyuan Pharmaceutical Co Ltd (000153) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.033x
Based on the latest financial reports, Anhui Fengyuan Pharmaceutical Co Ltd (000153) has a cash flow conversion efficiency ratio of 0.033x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥69.15 Million) by net assets (CN¥2.13 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Anhui Fengyuan Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (1999–2024)
This chart illustrates how Anhui Fengyuan Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Anhui Fengyuan Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Anhui Fengyuan Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Alvotech SDB
ST:ALVO-SDB
|
N/A |
|
Ooma Inc
NYSE:OOMA
|
0.077x |
|
MayAir Technology (China) Co. Ltd. A
SHG:688376
|
N/A |
|
Cosmecca Korea Co. Ltd
KQ:241710
|
0.053x |
|
Nanjing Huamai Tech Co Ltd
SHG:603042
|
-0.004x |
|
Deutsche Beteiligungs AG
XETRA:DBAN
|
0.004x |
|
Studio Dragon Corporation
KQ:253450
|
-0.037x |
|
Shanghai HiTech Control System
SHE:002184
|
-0.100x |
Annual Cash Flow Conversion Efficiency for Anhui Fengyuan Pharmaceutical Co Ltd (1999–2024)
The table below shows the annual cash flow conversion efficiency of Anhui Fengyuan Pharmaceutical Co Ltd from 1999 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥2.05 Billion | CN¥126.24 Million | 0.062x | -53.53% |
| 2023-12-31 | CN¥1.92 Billion | CN¥254.75 Million | 0.133x | -47.05% |
| 2022-12-31 | CN¥1.75 Billion | CN¥439.99 Million | 0.251x | +64.19% |
| 2021-12-31 | CN¥1.56 Billion | CN¥237.88 Million | 0.153x | -24.47% |
| 2020-12-31 | CN¥1.45 Billion | CN¥292.75 Million | 0.202x | +305.23% |
| 2019-12-31 | CN¥1.33 Billion | CN¥66.21 Million | 0.050x | -72.41% |
| 2018-12-31 | CN¥1.29 Billion | CN¥233.59 Million | 0.181x | +321.21% |
| 2017-12-31 | CN¥1.22 Billion | CN¥52.40 Million | 0.043x | -36.72% |
| 2016-12-31 | CN¥1.15 Billion | CN¥78.21 Million | 0.068x | +76.59% |
| 2015-12-31 | CN¥1.18 Billion | CN¥45.50 Million | 0.038x | +319.25% |
| 2014-12-31 | CN¥1.15 Billion | CN¥10.51 Million | 0.009x | +113.74% |
| 2013-12-31 | CN¥1.05 Billion | CN¥-70.31 Million | -0.067x | -213.22% |
| 2012-12-31 | CN¥775.01 Million | CN¥45.65 Million | 0.059x | -18.14% |
| 2011-12-31 | CN¥765.24 Million | CN¥55.06 Million | 0.072x | -1.45% |
| 2010-12-31 | CN¥753.81 Million | CN¥55.04 Million | 0.073x | +52.92% |
| 2009-12-31 | CN¥678.70 Million | CN¥32.41 Million | 0.048x | -37.32% |
| 2008-12-31 | CN¥654.09 Million | CN¥49.82 Million | 0.076x | -11.93% |
| 2007-12-31 | CN¥638.89 Million | CN¥55.26 Million | 0.086x | +47.97% |
| 2006-12-31 | CN¥620.49 Million | CN¥36.27 Million | 0.058x | +0.49% |
| 2005-12-31 | CN¥599.59 Million | CN¥34.88 Million | 0.058x | +393.43% |
| 2004-12-31 | CN¥591.07 Million | CN¥-11.72 Million | -0.020x | +0.35% |
| 2003-12-31 | CN¥576.00 Million | CN¥-11.46 Million | -0.020x | -206.51% |
| 2002-12-31 | CN¥560.87 Million | CN¥10.48 Million | 0.019x | -57.51% |
| 2001-12-31 | CN¥536.15 Million | CN¥23.57 Million | 0.044x | -9.55% |
| 2000-12-31 | CN¥532.50 Million | CN¥25.88 Million | 0.049x | +154.14% |
| 1999-12-31 | CN¥52.98 Million | CN¥1.01 Million | 0.019x | -- |